These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 16283274)
41. Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population. Halling J; Petersen MS; Damkier P; Nielsen F; Grandjean P; Weihe P; Lundgren S; Lundblad MS; Brøsen K Eur J Clin Pharmacol; 2005 Aug; 61(7):491-7. PubMed ID: 16025294 [TBL] [Abstract][Full Text] [Related]
42. Analysis of the CYP2D6 gene polymorphism and enzyme activity in African-Americans in southern California. Wan YJ; Poland RE; Han G; Konishi T; Zheng YP; Berman N; Lin KM Pharmacogenetics; 2001 Aug; 11(6):489-99. PubMed ID: 11505219 [TBL] [Abstract][Full Text] [Related]
43. CYP2D6 genetic polymorphisms in Southern Mexican Mayan Lacandones and Mestizos from Chiapas. López-López M; Peñas-Lledó E; Dorado P; Ortega A; Corona T; Ochoa A; Yescas P; Alonso E; LLerena A Pharmacogenomics; 2014; 15(15):1859-65. PubMed ID: 25495408 [TBL] [Abstract][Full Text] [Related]
44. Genetic polymorphism of cytochrome P450 2C19 in Mexican Americans: a cross-ethnic comparative study. Luo HR; Poland RE; Lin KM; Wan YJ Clin Pharmacol Ther; 2006 Jul; 80(1):33-40. PubMed ID: 16815315 [TBL] [Abstract][Full Text] [Related]
45. Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute pain. Ehret GB; Daali Y; Chabert J; Rebsamen M; Wolff A; Forster A; Moursli F; Fritschy D; Rossier MF; Piguet V; Dayer P; Gex-Fabry M; Desmeules JA Pain Physician; 2013 Jan; 16(1):45-56. PubMed ID: 23340533 [TBL] [Abstract][Full Text] [Related]
47. Patients with difficult-to-treat depression do not exhibit an increased frequency of CYP2D6 allele duplication. Háber A; Rideg O; Osváth P; Fekete S; Szücs F; Fittler A; Kovács GL; Miseta A; Botz L Pharmacopsychiatry; 2013 Jun; 46(4):156-60. PubMed ID: 23737191 [TBL] [Abstract][Full Text] [Related]
49. Prevalence of the CYP2D6*10 (C100T), *4 (G1846A), and *14 (G1758A) alleles among Iranians of different ethnicities. Bagheri A; Kamalidehghan B; Haghshenas M; Azadfar P; Akbari L; Sangtarash MH; Vejdandoust F; Ahmadipour F; Meng GY; Houshmand M Drug Des Devel Ther; 2015; 9():2627-34. PubMed ID: 25999696 [TBL] [Abstract][Full Text] [Related]
50. Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations. LLerena A; Naranjo ME; Rodrigues-Soares F; Penas-LLedó EM; Fariñas H; Tarazona-Santos E Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1569-83. PubMed ID: 25316321 [TBL] [Abstract][Full Text] [Related]
51. Analysis of Lithuanian CYP2D6 polymorphism and its relevance to psychiatric care of the local population. Dlugauskas E; Strumila R; Lengvenyte A; Ambrozaityte L; Dagyte E; Molyte A; Navickas A; Utkus A Nord J Psychiatry; 2019 Jan; 73(1):31-35. PubMed ID: 30661435 [TBL] [Abstract][Full Text] [Related]
52. CYP2D6 genotyping in patients on psychoactive drug therapy. Topić E; Stefanović M; Ivanisević AM; Blazinić F; Culav J; Skocilić Z Clin Chem Lab Med; 2000 Sep; 38(9):921-7. PubMed ID: 11097351 [TBL] [Abstract][Full Text] [Related]
53. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients. Lohmann PL; Bagli M; Krauss H; Müller DJ; Schulze TG; Fangerau H; Ludwig M; Barkow K; Held T; Heun R; Maier W; Rietschel M; Rao ML Pharmacopsychiatry; 2003; 36(2):73-8. PubMed ID: 12734765 [TBL] [Abstract][Full Text] [Related]
54. Endoxifen levels and its association with CYP2D6 genotype and phenotype: evaluation of a southern Brazilian population under tamoxifen pharmacotherapy. Antunes MV; Linden R; Santos TV; Wallemacq P; Haufroid V; Classen JF; Andreolla H; Costa N; Fontanive TO; Rosa DD Ther Drug Monit; 2012 Aug; 34(4):422-31. PubMed ID: 22777153 [TBL] [Abstract][Full Text] [Related]
55. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population. Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905 [TBL] [Abstract][Full Text] [Related]
56. CYP2D6 in Amerindians from Southern Mexico: low variability and higher frequency of functional alleles. Perez-Paramo YX; Hernandez-Cabrera F; Rojas-Martinez A; Ortiz-Lopez R Drug Metab Pers Ther; 2015 Dec; 30(4):231-8. PubMed ID: 26479352 [TBL] [Abstract][Full Text] [Related]
57. Clinical implications of genetic polymorphism of CYP2D6 in Mexican Americans. Flores DL; Alvarado I; Wong ML; Licinio J; Flockhart D Ann Intern Med; 2004 Jun; 140(11):W71. PubMed ID: 15172931 [No Abstract] [Full Text] [Related]
58. The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity. Dinh JC; Boone EC; Staggs VS; Pearce RE; Wang WY; Gaedigk R; Leeder JS; Gaedigk A Clin Pharmacol Ther; 2022 Mar; 111(3):646-654. PubMed ID: 34716917 [TBL] [Abstract][Full Text] [Related]
59. The Metabolization Profile of the Leitão LPC; Souza TP; Rodrigues JCG; Fernandes MR; Santos S; Santos NPC Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32121156 [TBL] [Abstract][Full Text] [Related]